SJP-L-5

N/A

Report date: 2023/01/14 18:58:08
NME

Base Information

Drug NameSJP-L-5
Drug Alias NameSJP-L-5
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHIV replication inhibitors
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesKunming Institute Of Botany, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesKunming Institute Of Botany, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A